2020
DOI: 10.1002/pat.5168
|View full text |Cite
|
Sign up to set email alerts
|

Targeted delivery, drug release strategies, and toxicity study of polymeric drug nanocarriers

Abstract: Science has been trying to deal with complex diseases, like cancer, for a long time. Indeed, the side effects of the conventional treatment methods are tremendous, in some cases irreversible. This kind of problems demands a solution. Therefore, novel drug delivery systems are devised to mitigate the negative impacts of conventional ones. Polymeric nanocarrier systems are of great importance in this newly opened field. Polymers having been vastly investigated are common in some properties, such as their being b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 103 publications
0
14
0
Order By: Relevance
“…The EPR effect is a deciding factor in drug release and delivery. In a recent approach, stimuli-responsive nanocarriers were developed where biological (internal) or physical (exogenous) stimuli were directed to specifically targeted cells after drug delivery and the precise release of the drug was achieved [108].…”
Section: Sustained Releasementioning
confidence: 99%
“…The EPR effect is a deciding factor in drug release and delivery. In a recent approach, stimuli-responsive nanocarriers were developed where biological (internal) or physical (exogenous) stimuli were directed to specifically targeted cells after drug delivery and the precise release of the drug was achieved [108].…”
Section: Sustained Releasementioning
confidence: 99%
“…This can be explained by the fact that practically all modern medicines act only on one of possibly many pathogenetic mechanisms of the appearance and development of the disease. Unfortunately, there is still no universal medicines that immediately affect all links in the pathogenesis of various wounds or change their structure depending on the biochemical characteristics of the wound [ 4 , 5 ]…”
Section: Introductionmentioning
confidence: 99%
“…Conventional methods of administration are incapable of ensuring the localized release of the active ingredient, which means that it will act both injured and healthy cells, causing side effects and demanding higher doses and frequent application 1–3 . Furthermore, some conventional drug delivery systems are limited due to some physicochemical properties of active molecules such as poor solubility, low permeability, instability, and rapid metabolism, which directly decrease their corresponding bioavailability and ultimately reduce the therapeutic effect of the drug 4,5 …”
Section: Introductionmentioning
confidence: 99%
“…It is well known that the efficiency of a given therapeutic agent depends on stablishing the molecular pharmacodynamics and pharmacokinetics that enable an effective administration dose at the target site 1,6 . Recently, studies have been conducted to develop devices capable of maintaining the therapeutic concentration of an active ingredient for long time intervals, controlling its release after the in vivo administration and, consequently, increasing the administration intervals and decreasing the side effects 2,5 . Such devices, or matrices, can be prepared in different shapes and are commonly referred to as controlled drug delivery systems 5 …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation